|
Health-related quality of life (HRQoL) and pain progression with enzalutamide (ENZ) in metastatic hormone-sensitive prostate cancer (mHSPC) from the ARCHES study. |
|
|
Consulting or Advisory Role - Alere; Bipsen Pharma; BMS Brazil; Janssen; Roche; Steba Biotech |
Research Funding - Astellas Pharma; AstraZeneca; Janssen; Karl Storz; Medivation |
Patents, Royalties, Other Intellectual Property - Patent A290/99 Implantable incontinence device, AT00/0001:C-Trap, implantable device to treat urinary incontinence 2018/6579 Gene-expression signature for subtype and prognostic prediction of renal cell carcinoma |
Expert Testimony - GBA Photodynamic therapy of prostate cancer |
Travel, Accommodations, Expenses - CureVac; Ferring; Ipsen; Janssen; Sanofi |
|
|
Consulting or Advisory Role - Pfizer |
Research Funding - Astellas Medivation (Inst); AstraZeneca (Inst); BHR Pharma (Inst); Churchill Pharmaceuticals (Inst); Dendreon (Inst); Eleven Biotherapeutics (Inst); Exact Sciences (Inst); Ferring (Inst); Janssen Oncology (Inst); Myovant Sciences (Inst); pfizer (Inst); Siemens (Inst); TesoRX Pharmaceuticals (Inst) |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Ferring; Janssen; MSD; Pfizer |
Speakers' Bureau - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Ferring; Janssen; MSD; Pfizer |
Research Funding - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Janssen; MSD |
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Ferring; Janssen; MSD; Pfizer; Sanofi |
|
|
Consulting or Advisory Role - Bayer; Janssen |
Speakers' Bureau - Astellas Pharma; Bayer; Janssen; Sanofi |
Research Funding - Astellas Pharma (Inst) |
|
|
Consulting or Advisory Role - Abbvie; Amgen; Astellas Pharma; AstraZeneca; Exelixis; Janssen Oncology; Merck; Pfizer; Sanofi |
Research Funding - Abbvie; Astellas Pharma; Incyte; Janssen Oncology; Macrogenics |
Patents, Royalties, Other Intellectual Property - Patent licensed by University of Chicago of which I am co-inventor to Corcept Therapeutics for combination AR/GR inhibition in prostate cancer |
Travel, Accommodations, Expenses - Corcept Therapeutics |
|
|
Leadership - Aurora Oncology |
Stock and Other Ownership Interests - Aurora Oncology |
Honoraria - BN ImmunoTherapeutics |
Consulting or Advisory Role - GTX |
Research Funding - Agensys; Aragon Pharmaceuticals; Astellas Pharma; astrazeneca/MedImmune; Bavarian Nordic; Bristol-Myers Squibb; Dendreon; Exelixis; GTx; Janssen Oncology; La Roche-Posay; Lilly; Medivation; Novartis; Pfizer; Roche/Genentech; Sanofi; Seagen; Sotio; Tokai Pharmaceuticals |
Patents, Royalties, Other Intellectual Property - The University of Colorado has filed 2 patents related in which I am an inventor. These are related to early-stage bladder cancer treatment and detection. Neither is commercialized or licensed at this time. |
|
|
Honoraria - Amgen; Astellas Pharma; Bayer; Ferring; Janssen; Pfizer; Sanofi |
Consulting or Advisory Role - Astellas Pharma; Bayer; Ferring; Janssen; Sanofi; Steba Biotech; Takeda |
Speakers' Bureau - Amgen; Janssen |
Research Funding - Ferring (Inst) |
Travel, Accommodations, Expenses - Amgen; Astellas Pharma; Bayer; Ferring; Janssen; Sanofi |
|
|
Consulting or Advisory Role - Abbott; Astellas Pharma; Ironwood Pharmaceuticals |
|
|
|
Research Funding - Astellas Pharma (Inst) |
|
|
|
Stock and Other Ownership Interests - Pfizer |
|
|
Honoraria - Abbvie; Amgen; Astellas Pharma; AstraZeneca; Bayer; Janssen Oncology; Sanofi |
Consulting or Advisory Role - Astellas Pharma; AstraZeneca/MedImmune; Bayer; Janssen Oncology; Sanofi |
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Janssen Oncology (Inst); Pfizer (Inst); Sanofi (Inst) |
|
|
Honoraria - Dendreon; Janssen Oncology; Sanofi |
Consulting or Advisory Role - Astellas Scientific and Medical Affairs Inc; AstraZeneca; Bayer; Clovis Oncology; Dendreon; Janssen Biotech; Medivation; Pfizer; Sanofi |
Speakers' Bureau - Bayer; Dendreon; Sanofi |
Research Funding - Active Biotech (Inst); Astellas Pharma (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Dendreon (Inst); Gilead Sciences (Inst); Janssen Oncology (Inst); Medivation (Inst); Novartis (Inst); Pfizer (Inst); Roche/Genentech (Inst); Sanofi (Inst) |
Patents, Royalties, Other Intellectual Property - Circulating tumor cell novel capture technology (Inst) |
Travel, Accommodations, Expenses - Astellas Scientific and Medical Affairs Inc; Bayer; Dendreon; Janssen Biotech |